HERBALIFE LTD. Cash and Cash Equivalents, Period Increase (Decrease)
HERBALIFE LTD. (HLF) reported Cash and Cash Equivalents, Period Increase (Decrease) of $434.80 million for the 12-month period ending 2017-12-31, per its 10-K filed 2018-02-22.
Discontinued › Cash Flow › Change in Cash
us-gaap:CashAndCashEquivalentsPeriodIncreaseDecrease · last filed 2018-02-22
- HERBALIFE LTD. cash and cash equivalents, period increase (decrease) for the quarter ending 2017-12-31 was -$357.50M, a 741.83% decline year-over-year.
- HERBALIFE LTD. cash and cash equivalents, period increase (decrease) for the quarter ending 2017-09-30 was $12.20M.
- HERBALIFE LTD. cash and cash equivalents, period increase (decrease) for the quarter ending 2017-06-30 was -$158.80M, a 197.72% decline year-over-year.
- HERBALIFE LTD. cash and cash equivalents, period increase (decrease) for the quarter ending 2017-03-31 was $938.90M.
- HERBALIFE LTD. cash and cash equivalents, period increase (decrease) for fiscal 2017 was $434.80M.
- HERBALIFE LTD. cash and cash equivalents, period increase (decrease) for fiscal 2016 was -$45.80M, a 118.74% decline from fiscal 2015.
- HERBALIFE LTD. cash and cash equivalents, period increase (decrease) for fiscal 2015 was $244.40M.
- HERBALIFE LTD. cash and cash equivalents, period increase (decrease) for fiscal 2014 was -$327.60M, a 151.23% decline from fiscal 2013.
| Period end | Cash and Cash Equivalents, Period Increase (Decrease) 3 month | Cash and Cash Equivalents, Period Increase (Decrease) 3 month as first filed | Cash and Cash Equivalents, Period Increase (Decrease) 6 month | Cash and Cash Equivalents, Period Increase (Decrease) 6 month as first filed | Cash and Cash Equivalents, Period Increase (Decrease) 9 month | Cash and Cash Equivalents, Period Increase (Decrease) 9 month as first filed | Cash and Cash Equivalents, Period Increase (Decrease) 12 month | Cash and Cash Equivalents, Period Increase (Decrease) 12 month as first filed |
|---|---|---|---|---|---|---|---|---|
| 2017-12-31 | -$357.50M derived: 10-K 12 month − 10-Q 9 month · filed 2018-02-22 | -$345.30M derived: sum of 2 quarters · filed 2018-02-22 | -$504.10M derived: sum of 3 quarters · filed 2018-02-22 | $434.80M 10-K · filed 2018-02-22 | ||||
| 2017-09-30 | $12.20M derived: 10-Q 9 month − 10-Q 6 month · filed 2017-11-02 | -$146.60M derived: sum of 2 quarters · filed 2017-11-02 | $792.30M 10-Q · filed 2017-11-02 | $848.00M derived: sum of 4 quarters · filed 2018-02-22 | ||||
| 2017-06-30 | -$158.80M derived: 10-Q 6 month − 10-Q 3 month · filed 2017-08-01 | $780.10M 10-Q · filed 2017-08-01 | $835.80M derived: sum of 3 quarters · filed 2018-02-22 | $687.40M derived: sum of 4 quarters · filed 2018-02-22 | ||||
| 2017-03-31 | $938.90M 10-Q · filed 2017-05-04 | $994.60M derived: sum of 2 quarters · filed 2018-02-22 | $846.20M derived: sum of 3 quarters · filed 2018-02-22 | $1.01B derived: sum of 4 quarters · filed 2018-02-22 | ||||
| 2016-12-31 | $55.70M derived: 10-K 12 month − 10-Q 9 month · filed 2018-02-22 | -$92.70M derived: sum of 2 quarters · filed 2018-02-22 | $69.80M derived: sum of 3 quarters · filed 2018-02-22 | -$45.80M 10-K · filed 2018-02-22 | ||||
| 2016-09-30 | -$148.40M derived: 10-Q 9 month − 10-Q 6 month · filed 2017-11-02 | $14.10M derived: sum of 2 quarters · filed 2017-11-02 | -$101.50M 10-Q · filed 2017-11-02 | -$24.90M derived: sum of 4 quarters · filed 2018-02-22 | ||||
| 2016-06-30 | $162.50M derived: 10-Q 6 month − 10-Q 3 month · filed 2017-08-01 | $46.90M 10-Q · filed 2017-08-01 | $123.50M derived: sum of 3 quarters · filed 2018-02-22 | $187.10M derived: sum of 4 quarters · filed 2018-02-22 | ||||
| 2016-03-31 | -$115.60M 10-Q · filed 2017-05-04 | -$39.00M derived: sum of 2 quarters · filed 2018-02-22 | $24.60M derived: sum of 3 quarters · filed 2018-02-22 | $58.70M derived: sum of 4 quarters · filed 2018-02-22 | ||||
| 2015-12-31 | $76.60M derived: 10-K 12 month − 10-Q 9 month · filed 2018-02-22 | $140.20M derived: sum of 2 quarters · filed 2018-02-22 | $174.30M derived: sum of 3 quarters · filed 2018-02-22 | $244.40M 10-K · filed 2018-02-22 | ||||
| 2015-09-30 | $63.60M derived: 10-Q 9 month − 10-Q 6 month · filed 2016-11-01 | $97.70M derived: sum of 2 quarters · filed 2016-11-01 | $167.80M 10-Q · filed 2016-11-01 | $135.00M derived: sum of 4 quarters · filed 2017-02-23 | ||||
| 2015-06-30 | $34.10M derived: 10-Q 6 month − 10-Q 3 month · filed 2016-08-03 | $104.20M 10-Q · filed 2016-08-03 | $71.40M derived: sum of 3 quarters · filed 2017-02-23 | -$23.90M derived: sum of 4 quarters · filed 2017-02-23 | ||||
| 2015-03-31 | $70.10M 10-Q · filed 2016-05-05 | $37.30M derived: sum of 2 quarters · filed 2017-02-23 | -$58.00M derived: sum of 3 quarters · filed 2017-02-23 | -$546.40M derived: sum of 4 quarters · filed 2017-02-23 | ||||
| 2014-12-31 | -$32.80M derived: 10-K 12 month − 10-Q 9 month · filed 2017-02-23 | -$128.10M derived: sum of 2 quarters · filed 2017-02-23 | -$616.50M derived: sum of 3 quarters · filed 2017-02-23 | -$327.60M 10-K · filed 2017-02-23 | ||||
| 2014-09-30 | -$95.30M derived: 10-Q 9 month − 10-Q 6 month · filed 2015-11-03 | -$583.70M derived: sum of 2 quarters · filed 2015-11-03 | -$294.80M 10-Q · filed 2015-11-03 | -$294.84M 10-Q · filed 2014-11-03 | -$214.31M derived: sum of 4 quarters · filed 2016-02-25 | |||
| 2014-06-30 | -$488.40M derived: 10-Q 6 month − 10-Q 3 month · filed 2015-08-05 | -$199.50M 10-Q · filed 2015-08-05 | -$199.46M 10-Q · filed 2014-07-28 | -$119.01M derived: sum of 3 quarters · filed 2016-02-25 | -$76.17M derived: sum of 4 quarters · filed 2016-02-25 | |||
| 2014-03-31 | $288.90M 10-Q · filed 2015-05-05 | $288.95M 10-Q · filed 2014-04-28 | $369.39M derived: sum of 2 quarters · filed 2016-02-25 | $412.23M derived: sum of 3 quarters · filed 2016-02-25 | $539.46M derived: sum of 4 quarters · filed 2016-02-25 | |||
| 2013-12-31 | $80.49M derived: 10-K 12 month − 10-Q 9 month · filed 2016-02-25 | $123.33M derived: sum of 2 quarters · filed 2016-02-25 | $250.56M derived: sum of 3 quarters · filed 2016-02-25 | $639.50M 10-K · filed 2016-02-25 | $639.44M 10-K · filed 2014-02-18 | |||
| 2013-09-30 | $42.84M derived: 10-Q 9 month − 10-Q 6 month · filed 2014-11-03 | $170.07M derived: sum of 2 quarters · filed 2014-11-03 | $559.01M 10-Q · filed 2014-11-03 | $570.77M derived: sum of 4 quarters · filed 2015-02-26 | ||||
| 2013-06-30 | $127.23M derived: 10-Q 6 month − 10-Q 3 month · filed 2014-07-28 | $516.17M 10-Q · filed 2014-07-28 | $527.92M derived: sum of 3 quarters · filed 2015-02-26 | $563.48M derived: sum of 4 quarters · filed 2015-02-26 | ||||
| 2013-03-31 | $388.94M 10-Q · filed 2014-04-28 | $400.69M derived: sum of 2 quarters · filed 2015-02-26 | $436.25M derived: sum of 3 quarters · filed 2015-02-26 | $416.55M derived: sum of 4 quarters · filed 2015-02-26 | ||||
| 2012-12-31 | $11.75M derived: 10-K 12 month − 10-Q/A 9 month · filed 2015-02-26 | $47.31M derived: sum of 2 quarters · filed 2015-02-26 | $27.61M derived: sum of 3 quarters · filed 2015-02-26 | $74.70M 10-K · filed 2015-02-26 | $74.76M 10-K · filed 2013-02-19 | |||
| 2012-09-30 | $35.56M derived: 10-Q/A 9 month − 10-Q/A 6 month · filed 2013-12-16 | $15.86M derived: sum of 2 quarters · filed 2013-12-16 | $62.95M 10-Q/A · filed 2013-12-16 | $60.20M derived: sum of 4 quarters · filed 2014-02-18 | ||||
| 2012-06-30 | -$19.70M derived: 10-Q/A 6 month − 10-Q/A 3 month · filed 2013-12-16 | $27.39M 10-Q/A · filed 2013-12-16 | $24.64M derived: sum of 3 quarters · filed 2014-02-18 | $31.70M derived: sum of 4 quarters · filed 2014-02-18 | ||||
| 2012-03-31 | $47.09M 10-Q/A · filed 2013-12-16 | $44.34M derived: sum of 2 quarters · filed 2014-02-18 | $51.39M derived: sum of 3 quarters · filed 2014-02-18 | $45.09M derived: sum of 4 quarters · filed 2014-02-18 | ||||
| 2011-12-31 | -$2.75M derived: 10-K 12 month − 10-Q 9 month · filed 2014-02-18 | $4.31M derived: sum of 2 quarters · filed 2014-02-18 | -$1.99M derived: sum of 3 quarters · filed 2014-02-18 | $68.22M 10-K · filed 2014-02-18 | ||||
| 2011-09-30 | $7.05M derived: 10-Q 9 month − 10-Q 6 month · filed 2012-10-29 | $755.00K derived: sum of 2 quarters · filed 2012-10-29 | $70.97M 10-Q · filed 2012-10-29 | $68.03M derived: sum of 4 quarters · filed 2013-12-16 | ||||
| 2011-06-30 | -$6.30M derived: 10-Q 6 month − 10-Q 3 month · filed 2012-07-30 | $63.92M 10-Q · filed 2012-07-30 | $60.98M derived: sum of 3 quarters · filed 2013-12-16 | $84.25M derived: sum of 4 quarters · filed 2013-12-16 | ||||
| 2011-03-31 | $70.22M 10-Q · filed 2012-04-30 | $67.28M derived: sum of 2 quarters · filed 2013-12-16 | $90.55M derived: sum of 3 quarters · filed 2013-12-16 | $95.50M derived: sum of 4 quarters · filed 2013-12-16 | ||||
| 2010-12-31 | -$2.94M derived: 10-K/A 12 month − 10-Q 9 month · filed 2013-12-16 | $20.33M derived: sum of 2 quarters · filed 2013-12-16 | $25.28M derived: sum of 3 quarters · filed 2013-12-16 | $39.75M 10-K/A · filed 2013-12-16 | ||||
| 2010-09-30 | $23.27M derived: 10-Q 9 month − 10-Q 6 month · filed 2011-10-31 | $28.22M derived: sum of 2 quarters · filed 2011-10-31 | $42.69M 10-Q · filed 2011-10-31 | -$21.91M derived: sum of 4 quarters · filed 2012-04-11 | ||||
| 2010-06-30 | $4.95M derived: 10-Q 6 month − 10-Q 3 month · filed 2011-08-01 | $19.42M 10-Q · filed 2011-08-01 | -$45.18M derived: sum of 3 quarters · filed 2012-04-11 | -$11.22M derived: sum of 4 quarters · filed 2012-04-11 | ||||
| 2010-03-31 | $14.47M 10-Q · filed 2011-05-02 | -$50.13M derived: sum of 2 quarters · filed 2012-04-11 | -$16.16M derived: sum of 3 quarters · filed 2012-04-11 | |||||
| 2009-12-31 | -$64.60M derived: 10-K/A 12 month − 10-Q 9 month · filed 2012-04-11 | -$30.64M derived: sum of 2 quarters · filed 2012-04-11 | -$46.00K 10-K/A · filed 2012-04-11 | |||||
| 2009-09-30 | $33.97M derived: 10-Q 9 month − 10-Q 6 month · filed 2010-11-01 | $64.55M 10-Q · filed 2010-11-01 | ||||||
| 2009-06-30 | $30.59M 10-Q · filed 2010-08-02 | |||||||
| 2008-12-31 | -$36.56M 10-K · filed 2011-02-22 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| NU SKIN ENTERPRISES, INC. (NUS) | United States | $0.225B | -1.18 |
| Cosmos Health Inc. (COSM) | Greece | $0.038B | -0.60 |
| HWH International Inc. (HWH) | United States | $0.021B | -4.08 |
| DataMeds AI, Inc. (MEDS) | United States | $0.011B | |
| CARDINAL HEALTH INC (CAH) | United States | $51.753B | 29.38 |
| Cencora, Inc. (COR) | United States | $59.130B | 20.57 |
| MCKESSON CORP (MCK) | United States | $101.317B | 19.78 |